Advertisement

Topics

Final NICE nod for Janssen’s Tremfya

06:32 EDT 14 Jun 2018 | PharmaTimes

The National Institute for Health and Care Excellence (NICE) has now issued guidance recommending Janssen’s Tremfya as an option for treating plaque psoriasis in adults on the NHS.

Original Article: Final NICE nod for Janssen’s Tremfya

NEXT ARTICLE

More From BioPortfolio on "Final NICE nod for Janssen’s Tremfya"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Psoriasis
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the replacement of skin cells. Patients experience an accumulat...